LCID
Lucid Group, Inc.
LCID offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
PVH
PVH Corp.
PVH has the edge over LCID overall, supported by lower modeled downside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
PVH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Stable |
PVH's cash flow is currently healthy, and its revenue and balance sheet are stable, but its profitability is under pressure.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
PVH PE Valuation
PVH has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
PVH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect PVH's earnings to grow, with its revenue and profitability holding steady.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID has the edge over PVH on earnings, with more consistent year-over-year improvement.
PVH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $11.54 | — |
| Q3 2026 | -$3.56 | -140% |
| Q2 2026 | $3.30 | -53% |
| Q1 2026 | $0.52 | -95% |
| Q4 2025 | $6.67 | -45% |
| Q3 2025 | $8.92 | -29% |
| Q2 2025 | $7.09 | -37% |
| Q1 2025 | $10.56 | -1.9% |
| Q4 2024 | $12.19 | +43% |
PVH has swung to a loss: it lost $3.56 per share over the past year, after a profit the year before.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over PVH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
PVH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.1B | -3.2% |
| Q2 2026 | $2B | +2.1% |
| Q1 2026 | $2.5B | +5.6% |
| Q4 2025 | $2.3B | +1.7% |
| Q3 2025 | $2.2B | +4.5% |
| Q2 2025 | $2B | +1.6% |
| Q1 2025 | $2.4B | -4.8% |
| Q4 2024 | $2.3B | -4.6% |
PVH's revenue fell from its 2020 peak and has held roughly level since: $2.1B last quarter, down 3.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -9.1% | -15 points |
| Q2 2026 | 6.1% | +23 points |
| Q1 2026 | 9.9% | +1.1 points |
| Q4 2025 | 7.9% | -0.2 points |
| Q3 2025 | 6.2% | -2.2 points |
| Q2 2025 | -17% | -27 points |
| Q1 2025 | 8.9% | -5.5 points |
| Q4 2024 | 8.1% | -1.6 points |
PVH has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
PVH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $346.4M | +90% |
| Q2 2026 | -$86M | +$12.1M |
| Q1 2026 | $539.7M | +22% |
| Q4 2025 | -$85.1M | -$73.8M |
| Q3 2025 | $181.9M | -29% |
| Q2 2025 | -$98.1M | +$7.4M |
| Q1 2025 | $443.2M | -23% |
| Q4 2024 | -$11.3M | -117% |
PVH has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PVH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.1x | Moderate |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 3.2x | Elevated |
| Q4 2025 | 4.5x | High |
| Q3 2025 | 4.3x | High |
| Q2 2025 | 4.2x | High |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.3x | Healthy |
PVH's net debt is about 2.1 years of its operating earnings (EBITDA), down from 4.3 years a year ago.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
PVH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.1 | Neutral |
| Stochastic | 83.7 | Overbought |
PVH's weekly RSI is 63 (neutral) and its Stochastic is 84 (overbought).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
PVH PE vs Consumer Cyclical Sector
| Metric | PVH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
PVH has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
PVH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $84.4 | 9.8% above |
| 20 week MA | $80.9 | 15% above |
| 50 week MA | $77.5 | 20% above |
| 100 week MA | $78.2 | 19% above |
| 200 week MA | $88.1 | 5.2% above |
PVH has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
PVH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $104.1 | $93.8 | -9.8% |
| 2021 | $93.8 | $100.3 | +6.9% |
| 2022 | $100.3 | $70.1 | -30% |
| 2023 | $70.1 | $122.1 | +74% |
| 2024 | $122.1 | $107.5 | -12% |
| 2025 | $107.5 | $68.7 | -36% |
| 2026 YTD | $68.7 | $92.7 | +35% |
PVH has the edge over LCID on returns for 2026, with the stronger performance.